ozempic to glp-1 alternative transition programs Weight-loss drugs such as were in the headlines a lot in 2025 – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Comparing Ozempic, Wegovy and Other

And the data suggests it might be more effective than some of its competitors

*Frequency individualized based on physician assessment

Your provider determines whether GLOW Blend peptide therapy may be appropriate

Kidney stones are a common and extremely painful condition

They: Make you feel full sooner Help you eat less (also known to reduce cravings) Slow down your digestion Help control your blood sugar (by enhancing insulin release and inhibiting glucagon release) Who are these medications approved for in the UK

Chronic interferon- decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates